Medical and Pharmaceutical Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s Analysts have now given the company a much higher share target price too Rowan DunneSeptember 9, 2024
Medical and Pharmaceutical United Kingdom’s NHS stresses need for higher cancer screening rates Every year five million people who should get checked out do not, the health service says Rowan DunneSeptember 3, 2024
Medical and Pharmaceutical First-ever global lung cancer vaccine trial kicks off in the UK It uses the same mRNA technology as the COVID vaccine Rowan DunneAugust 30, 2024
Medical and Pharmaceutical Lung cancer diagnostics clinic opens up at Ontario hospital Oakville Trafalgar Memorial Hospital's Lung Diagnostic Assessment Program offers 4 diagnostic procedures Rowan DunneAugust 29, 2024
Medical and Pharmaceutical American cancer screening: a US$43 billion dollar business That number comes from a study published this month in the journal 'Annals of Internal Medicine' Rowan DunneAugust 28, 2024
Medical and Pharmaceutical University of Notre Dame develops novel blood testing method for brain cancer Although considered incurable, they hope early detection of glioblastoma may increase a person's survival chances Rowan DunneAugust 27, 2024
Medical and Pharmaceutical Breath Diagnostics pioneers novel lung cancer breath test Development of a 'MicroReactor' has given the company a superior advantage over other breath analysis tech Rowan DunneAugust 23, 2024
Health & Wellness WELL Health and Healwell AI join forces to produce more efficient hospitals OceanMD eliminates inefficiencies of paper-based processes by direct integration with electronic medical records systems Joseph MortonAugust 22, 2024
AI and Autonomy AI therapy app ‘Feeling Great’ makes American debut Feeling Great, inspired by distinguished psychiatrist Dr. David Burns, just raised US$8 million in a seed round Rowan DunneAugust 8, 2024
Psychedelics U.S. invests millions in psychedelics research to treat chronic pain in older adults The initiative has potential to greatly expand the range of treatment options available Rowan DunneApril 30, 2024